Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso

Jean Moise Tanga Kaboré, Mohamadou Siribié, Denise Hien, Issiaka Soulama, Nouhoun Barry, Yacouba Nombré, Frederic Dianda, Adama Baguiya, Alfred Bewendtaoré Tiono, Christian Burri, André-Marie Tchouatieu, Sodiomon Bienvenu Sirima, Jean Moise Tanga Kaboré, Mohamadou Siribié, Denise Hien, Issiaka Soulama, Nouhoun Barry, Yacouba Nombré, Frederic Dianda, Adama Baguiya, Alfred Bewendtaoré Tiono, Christian Burri, André-Marie Tchouatieu, Sodiomon Bienvenu Sirima

Abstract

Background: Malaria case management relies on World Health Organization (WHO)-recommended artemisinin-based combination therapy (ACT), and a continuous understanding of local community knowledge, attitudes, and practices may be a great support for the success of malaria disease control efforts. In this context, this study aimed to identify potential facilitators or barriers at the community level to inform a health district-wide implementation of multiple first-line therapies (MFT) as a new strategy for uncomplicated malaria case management.

Methods: A community-based cross-sectional study using a mixed-method design was carried out from November 2018 to February 2019, in the health district (HD) of Kaya in Burkina Faso. Quantitative data were collected using a standardized questionnaire from 1394 individuals who had fever/malaria episodes four weeks prior to the survey. In addition, 23 focus group discussions (FGDs) were conducted targeting various segments of the community. Logistic regression models were used to assess the predictors of community care-seeking behaviours.

Results: Overall, 98% (1366/1394) of study participants sought advice or treatment, and 66.5% did so within 24 h of fever onset. 76.4% of participants preferred to seek treatment from health centres as the first recourse to care, 5.8% were treated at home with remaining drug stock, and 2.3% preferred traditional healers. Artemether-lumefantrine (AL) was by far the most used anti-malarial drug (98.2%); reported adherence to the 3-day treatment regimen was 84.3%. Multivariate analysis identified less than 5 km distance travelled for care (AOR = 2.7; 95% CI 2.1-3.7) and education/schooling (AOR = 1.8; 95% CI 1.3-2.5) as determinants of prompt care-seeking for fever. Geographical proximity (AOR = 1.5, 95% CI 1.2-2.1), having a child under five (AOR = 4.6, 95% CI 3.2-6.7), being pregnant (AOR = 6.5, 95% CI 1.9-22.5), and living in an urban area (AOR = 2.8, 95% CI 1.8-4.2) were significant predictors for visiting health centres. The FGDs showed that participants had good knowledge about malaria symptoms, prevention tools, and effective treatment. Behaviour change regarding malaria treatment and free medication for children under five were the main reasons for participants to seek care at health centres.

Conclusions: The study showed appropriate knowledge about malaria and positive community care-seeking behaviour at health centres for fever/malaria episodes. This could potentially facilitate the implementation of a MFT pilot programme in the district.

Clinicaltrials: gov Identifier: NCT04265573.

Keywords: Burkina Faso; Care-seeking behaviour; Malaria; Multiple first-line therapies.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Map of Heath facilities in the HD of Kaya

References

    1. WHO . World malaria report 2021. Geneva: World Health Organization; 2021.
    1. Ministère de la santé. Secrétariat Général, Direction Générale des Etudes et des Statistiques Sectorielles, Burkina Faso. Annuaire Statistique 2020. Ouagadougou, 2021.
    1. President's malaria initiative. Burkina Faso Malaria Operational Plan FY 2018.
    1. Bicaba F, Browne L, Kadio K, Bila A, Bicaba A, Druetz T. National user fee abolition and health insurance scheme in Burkina Faso: How can they be integrated on the road to universal health coverage without increasing health inequities? J Glob Health. 2020;10:010319. doi: 10.7189/jogh.10.010319.
    1. Chaturvedi HK, Mahanta J, Pandey A. Treatment-seeking for febrile illness in north-east India: an epidemiological study in the malaria endemic zone. Malar J. 2009;8:301. doi: 10.1186/1475-2875-8-301.
    1. Druetz T, Fregonese F, Bado A, Millogo T, Kouanda S, Diabate S, et al. Abolishing fees at Health Centers in the context of community case management of malaria: what effects on treatment-seeking practices for febrile children in rural Burkina Faso? PLoS ONE. 2015;10:e0141306. doi: 10.1371/journal.pone.0141306.
    1. Ogbonna A, Uneke CJ. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000. Trans R Soc Trop Med Hyg. 2008;102:621–627. doi: 10.1016/j.trstmh.2008.03.024.
    1. Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, Pagnoni F. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health. 2003;8:133–139. doi: 10.1046/j.1365-3156.2003.00997.x.
    1. Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malar J. 2014;13:7. doi: 10.1186/1475-2875-13-7.
    1. Bruxvoort K, Goodman C, Kachur SP, Schellenberg D. How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs. PLoS ONE. 2014;9:e84555. doi: 10.1371/journal.pone.0084555.
    1. Afaya A, Salia SM, Adatara P, Afaya RA, Suglo S, Japiong M. Patients' knowledge of artemisinin-based combination therapy treatment and its impact on patient adherence. J Trop Med. 2018;2018:7465254. doi: 10.1155/2018/7465254.
    1. Watsierah CA, Jura WG, Raballah E, Kaseje D, Abong'o B, Ouma C. Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Malar J. 2011;10:99. doi: 10.1186/1475-2875-10-99.
    1. Beiersmann C, Sanou A, Wladarsch E, De Allegri M, Kouyate B, Muller O. Malaria in rural Burkina Faso: local illness concepts, patterns of traditional treatment and influence on health-seeking behaviour. Malar J. 2007;6:106. doi: 10.1186/1475-2875-6-106.
    1. Ntamabyaliro NY, Burri C, Lula YN, Ishoso D, Engo AB, Ngale MA, et al. Knowledge of antimalarials and health seeking behaviour of households in case of suspected malaria in Democratic Republic of the Congo. Trop Med Infect Dis. 2021;6:157. doi: 10.3390/tropicalmed6030157.
    1. Adjei GO, Darkwah AK, Goka BQ, Bart-Plange C, Alifrangis ML, Kurtzhals JA, et al. Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana. Ghana Med J. 2009;43:99–106.
    1. Onyango EO, Ayodo G, Watsierah CA, Were T, Okumu W, Anyona SB, et al. Factors associated with non-adherence to artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya. BMC Infect Dis. 2012;12:143. doi: 10.1186/1471-2334-12-143.
    1. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–1966. doi: 10.1016/S0140-6736(12)60484-X.
    1. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis. 2012;12:851–858. doi: 10.1016/S1473-3099(12)70181-0.
    1. Thanh NV, Thuy-Nhien N, Tuyen NT, Tong NT, Nha-Ca NT, Dong LT, et al. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam. Malar J. 2017;16:27. doi: 10.1186/s12936-017-1680-8.
    1. Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Aye MM, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS ONE. 2013;8:e57689. doi: 10.1371/journal.pone.0057689.
    1. Imwong M, Hien TT, Thuy-Nhien NT, Dondorp AM, White NJ. Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam. Lancet Infect Dis. 2017;17:1022–1023. doi: 10.1016/S1473-3099(17)30524-8.
    1. Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491–497. doi: 10.1016/S1473-3099(17)30048-8.
    1. Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, et al. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial. Lancet Infect Dis. 2016;16:189–198. doi: 10.1016/S1473-3099(15)00318-7.
    1. West African Network for Clinical Trials of Antimalarial D. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. Lancet. 2018;391:1378–90.
    1. Boni MF, Smith DL, Laxminarayan R. Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci USA. 2008;105:14216–14221. doi: 10.1073/pnas.0804628105.
    1. Smith DL, Klein EY, McKenzie FE, Laxminarayan R. Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty. Malar J. 2010;9:217. doi: 10.1186/1475-2875-9-217.
    1. Siribie M, Tchouatieu AM, Soulama I, Kabore JMT, Nombre Y, Hien D, et al. Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district. Burkina Faso BMJ Open. 2021;11:e040220.
    1. Kabanywanyi AM, Lengeler C, Kasim P, King'eng'ena S, Schlienger R, Mulure N, et al. Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania. Malar J. 2010;9:48. doi: 10.1186/1475-2875-9-48.
    1. Tipke M, Louis VR, Ye M, De Allegri M, Beiersmann C, Sie A, et al. Access to malaria treatment in young children of rural Burkina Faso. Malar J. 2009;8:266. doi: 10.1186/1475-2875-8-266.
    1. Awantang G, Babalola S, Koenker H, Fox K, Toso M, Lewicky N, et al. Correlates of social behavior change communication on care-seeking behaviors for children with fever: an analysis of malaria household survey data from Liberia. Malar J. 2018;17:105. doi: 10.1186/s12936-018-2249-x.
    1. Mitiku I, Assefa A. Caregivers' perception of malaria and treatment-seeking behaviour for under five children in Mandura District, West Ethiopia: a cross-sectional study. Malar J. 2017;16:144. doi: 10.1186/s12936-017-1798-8.
    1. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, et al. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J. 2011;10:327. doi: 10.1186/1475-2875-10-327.
    1. Adhikari B, Phommasone K, Pongvongsa T, Koummarasy P, Soundala X, Henriques G, et al. Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study. BMC Health Serv Res. 2019;19:252. doi: 10.1186/s12913-019-4070-9.
    1. Millar KR, McCutcheon J, Coakley EH, Brieger W, Ibrahim MA, Mohammed Z, et al. Patterns and predictors of malaria care-seeking, diagnostic testing, and artemisinin-based combination therapy for children under five with fever in Northern Nigeria: a cross-sectional study. Malar J. 2014;13:447. doi: 10.1186/1475-2875-13-447.
    1. Khairy S, Al-Surimi K, Ali A, Shubily HM, Al Walaan N, Househ M, et al. Knowledge, attitude and practice about malaria in south-western Saudi Arabia: a household-based cross-sectional survey. J Infect Public Health. 2017;10:499–506. doi: 10.1016/j.jiph.2016.09.021.
    1. Klootwijk L, Chirwa AE, Kabaghe AN, van Vugt M. Challenges affecting prompt access to adequate uncomplicated malaria case management in children in rural primary health facilities in Chikhwawa Malawi. BMC Health Serv Res. 2019;19:735. doi: 10.1186/s12913-019-4544-9.
    1. Romay-Barja M, Cano J, Ncogo P, Nseng G, Santana-Morales MA, Valladares B, et al. Determinants of delay in malaria care-seeking behaviour for children 15 years and under in Bata district. Equatorial Guinea Malar J. 2016;15:187.
    1. Workineh B, Mekonnen FA. Early treatment-seeking behaviour for malaria in febrile patients in northwest Ethiopia. Malar J. 2018;17:406. doi: 10.1186/s12936-018-2556-2.
    1. Getahun A, Deribe K, Deribew A. Determinants of delay in malaria treatment-seeking behaviour for under-five children in south-west Ethiopia: a case control study. Malar J. 2010;9:320. doi: 10.1186/1475-2875-9-320.
    1. Cassy A, Saifodine A, Candrinho B, Martins MDR, da Cunha S, Pereira FM, et al. Care-seeking behaviour and treatment practices for malaria in children under 5 years in Mozambique: a secondary analysis of 2011 DHS and 2015 IMASIDA datasets. Malar J. 2019;18:115. doi: 10.1186/s12936-019-2751-9.
    1. Anselmi L, Lagarde M, Hanson K. Health service availability and health seeking behaviour in resource poor settings: evidence from Mozambique. Heal Econ Rev. 2015;5:62.
    1. Thandar MM, Kyaw MP, Jimba M, Yasuoka J. Caregivers' treatment-seeking behaviour for children under age five in malaria-endemic areas of rural Myanmar: a cross-sectional study. Malar J. 2015;14:1. doi: 10.1186/1475-2875-14-1.
    1. Ingabire CM, Kateera F, Hakizimana E, Rulisa A, Muvunyi C, Mens P, et al. Determinants of prompt and adequate care among presumed malaria cases in a community in eastern Rwanda: a cross sectional study. Malar J. 2016;15:227. doi: 10.1186/s12936-016-1285-7.
    1. Romay-Barja M, Jarrin I, Ncogo P, Nseng G, Sagrado MJ, Santana-Morales MA, et al. Rural-urban differences in household treatment-seeking behaviour for suspected malaria in children at Bata District Equatorial Guinea. PLoS ONE. 2015;10:e0135887. doi: 10.1371/journal.pone.0135887.
    1. Diaz T, George AS, Rao SR, Bangura PS, Baimba JB, McMahon SA, et al. Healthcare seeking for diarrhoea, malaria and pneumonia among children in four poor rural districts in Sierra Leone in the context of free health care: results of a cross-sectional survey. BMC Public Health. 2013;13:157. doi: 10.1186/1471-2458-13-157.
    1. Wilkinson D, Gouws E, Sach M, Karim SS. Effect of removing user fees on attendance for curative and preventive primary health care services in rural South Africa. Bull World Health Organ. 2001;79:665–671.
    1. Ministère de la santé. PNLP, Directives Nationales pour la prise en charge du paludisme dans les formations sanitaires du Burkina Faso. Ouagadougou, 2017.
    1. Rouamba T, Sondo P, Yerbanga IW, Compaore A, Traore-Coulibaly M, Hien FS, et al. High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro Burkina Faso. Patient Prefer Adherence. 2019;13:371–380. doi: 10.2147/PPA.S190927.
    1. Simba DO, Kakoko D, Tomson G, Premji Z, Petzold M, Mahindi M, et al. Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania. Trans R Soc Trop Med Hyg. 2012;106:3–9. doi: 10.1016/j.trstmh.2011.09.006.
    1. Ogolla JO, Ayaya SO, Otieno CA. Levels of adherence to coartem(c) in the routine treatment of uncomplicated malaria in children aged below five years, in kenya. Iran J Public Health. 2013;42:129–133.
    1. White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malar J. 2009;8:253. doi: 10.1186/1475-2875-8-253.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren